Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
about
5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancerAntimetabolites and cancer: emerging data with a focus on antifolates.5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapy.Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil.Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects.Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations.Mutations at codon 974 of the DPYD gene are a rare event.Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.Characterization of dihydropyrimidine dehydrogenase in human colorectal tumoursProfound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients.Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.The value of dihydrouracil/uracil plasma ratios in predicting 5-fluorouracil-related toxicity in colorectal cancer patients.Lack of interaction between bropirimine and 5-fluorouracil on human dihydropyrimidine dehydrogenase.Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients.
P2860
Q28359288-12280E7C-330E-43C3-A651-579A3A920409Q33530405-C5FF6789-3525-460C-82DD-A321DD8ADFD7Q33750445-C890ACC4-39BA-4EC2-BF1D-057592FAD7BBQ33960326-59E1BF97-785E-45FC-9C89-2C032E931124Q34761260-2CE7714F-5C14-4406-B944-488E6C2CDF48Q35802542-3C63AE2E-E1B0-4996-B95E-CB1C268C8CEFQ36055251-443A8A33-397E-4F38-8311-6A70C055381CQ36116010-85839453-82A9-4AFD-948A-C95BF1E1775EQ36295110-D4C7F0E8-D4D2-4A6D-80B8-9F4F500CE721Q36295138-E6150362-0FD1-45E7-B843-6BA3472C2484Q36618173-E1288ED4-C763-42EE-95A4-1A0BAC03FBBCQ37358027-14C64C0C-4211-48FB-962F-AEB87CEC38F7Q42868390-0AD45568-050E-47EF-B73B-12134FC2E5D6Q43595877-20584D0A-80D6-4C48-A644-E165CE32F855Q53513271-5BBC5D1F-00DC-4F16-A719-FF5A5CFE2007
P2860
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
@ast
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
@en
type
label
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
@ast
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
@en
prefLabel
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
@ast
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
@en
P1476
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
@en
P2093
H L McLeod
J McMurrough
P304
P356
10.1046/J.1365-2125.1996.34212.X
P407
P577
1996-05-01T00:00:00Z